Intelligence · Patents

Patents expiring in 2030

Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.

Patents
880

Quick answer

880 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7777069

    Prodrugs of carbamate inhibitors of IMPDH

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7777019

    Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7776905

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7781565

    Compositions and methods related to profiling a plurality of cells based on peptide binding

    The Board of Regents of the University of Texas System · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7781577

    Inhibitors of sodium glucose co-transporter 2 and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7781448

    Once daily dosage forms of trospium

    Supernus Pharmaceuticals, Inc. · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7781478

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7781584

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7781413

    SEMA3B inhibits tumor growth and induces apoptosis in cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7781449

    Trospium chloride treatment method

    Supernus Pharmaceuticals, Inc. · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7781175

    Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7781397

    Human plasma hyaluronidase

    The Regents of the University of California · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7780963

    Anti-ADDL antibodies and uses thereof

    Northwestern University · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7780966

    Artificial invaplex

    The United States of America as represented by the Secretary of the Army · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7781404

    IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7781445

    Synthesis of indenoisoquinoliniums and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7786285

    Recombinant vaccine against botulinum neurotoxin

    The United States of America as represented by the Secretary of the Army · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7785565

    Metal chelators and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7786290

    Double-stranded ribonucleic acid with increased effectiveness in an organism

    Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7785597

    VMP-like sequences of pathogenic Borrelia

    The Board of Regents of the University of Texas System · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7785806

    Method for determining the immunogenicity of an antigen

    VaxDesign Corp. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7785886

    Methods and reagents for modulating cholesterol levels

    Xenon Pharmaceuticals Inc. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7784616

    Dispenser for progestin used for acute maintenance treatment of DUB

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7786080

    Mutein of a bone morphogenetic protein and use thereof

    Julius-Maximilians-Universitat Wurzburg · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7786091

    Compositions and methods for ameliorating myosin VIIa defects

    The Regents of the University of California · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7786100

    Composition and method of treating hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7786133

    Chemically modified small molecules

    Nektar Therapeutics · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7786136

    Indazole-carboxamide compounds

    Theravance, Inc. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7786141

    Dihydrospiroindene modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7786130

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7786213

    Biomacromolecule polymer conjugates

    The Regents of the University of California · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7786221

    Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules

    Nektar Therapeutics · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7786282

    Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain

    The Regents of the University of California · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7786308

    Muscarinic modulators

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7788045

    Systems and method for homeostatic blood states

    MEDITASKS, LLC · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7786107

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7786149

    Thiadiazoles as CXC- and CC- chemokine receptor ligands

    Pharmacopeia Drug Discovery, Inc. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7786083

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7786096

    Inhibition of antigen presentation with poorly catabolized polymers

    HALOZYME, INC. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7786120

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7786137

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7786165

    Aminophenylpropanoic acid derivative

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7786316

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7790182

    Protein vaccines against poxviruses

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7790039

    Tangential flow filtration devices and methods for stem cell enrichment

    Northwest Biotherapeutics, Inc. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7790158

    Methods for epitope-specific and cytokine/anticytokine combination immunotherapies

    The Regents of the University of California · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7790159

    Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7790181

    Live attenuated viral vaccines for Eastern Equine Encephalitis virus

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2030?

880 published patents in our USPTO index have expiration dates falling in calendar year 2030.